Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Genenta Science S.p.A. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 5 | 6 | +1 |
| Shares | 537.3K | 552.0K | +14.7K (+2.7%) |
| Value | $1.82M | $1.77M | −$56.0K (−3.1%) |
New holders (2)
Institutions that held Genenta Science S.p.A. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 12,486 | $41.0K | 0.00% |
| National Bank of Canada | 3,000 | $9.54K | 0.00% |
Sold out (1)
Institutions that held Genenta Science S.p.A. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| EverSource Wealth Advisors, LLC | 982 | $2.99K |